BiotechTube
Home/Theravance Biopharma/Rhonda F. Farnum
RF

Rhonda F. Farnum

Senior Vice President, Commercial and Medical Affairs and Chief Business Officer

Theravance Biopharma

Therapeutic Areas

RespiratoryChronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Pipeline

DrugIndicationPhase
YUPELRI® (revefenacin)Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD)Approved
TD-0903Inflammatory Lung Disease (e.g., previously COVID-19)Phase 2
Nebulized Lung-Selective BispecificsSerious Respiratory DiseasesPreclinical
Oral Lung-Selective BispecificsSerious Respiratory DiseasesPreclinical

Leadership Team at Theravance Biopharma

RE
Rick E Winningham
Chief Executive Officer
BG
Brett Grimaud
Senior Vice President, General Counsel and Secretary
LS
Laurie Smaldone Alsup
Director
View full Theravance Biopharma profile